相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2
Ekaterina Gavrish et al.
CHEMISTRY & BIOLOGY (2014)
Discovery and Characterization of the Tuberculosis Drug Lead Ecumicin
Wei Gao et al.
ORGANIC LETTERS (2014)
Mycobacterial Esx-3 Requires Multiple Components for Iron Acquisition
M. Sloan Siegrist et al.
MBIO (2014)
Structural Basis of Mycobacterial Inhibition by Cyclomarin A
Dileep Vasudevan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
A. H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring
Tatos Akopian et al.
EMBO JOURNAL (2012)
Mycobacterium abscessus: a new antibiotic nightmare
Rachid Nessar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future
Christian Lienhardt et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Bacterial proteolytic complexes as therapeutic targets
Ravikiran M. Raju et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
New insights on the structure of the anti-TB peptide H14: Crystal structure, 1H NMR full spin analysis, and biosynthetic pathway
W Gao et al.
PLANTA MEDICA (2012)
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
Scott G. Franzblau et al.
TUBERCULOSIS (2012)
Mycobacterium tuberculosis ClpP1 and ClpP2 Function Together in Protein Degradation and Are Required for Viability in vitro and During Infection
Ravikiran M. Raju et al.
PLOS PATHOGENS (2012)
TB and HIV Therapeutics: Pharmacology Research Priorities
Kelly E. Dooley et al.
AIDS RESEARCH AND TREATMENT (2012)
The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease
Esther K. Schmitt et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Nitroimidazoles for the treatment of TB: past, present and future
Tathagata Mukherjee et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Wanliang Shi et al.
SCIENCE (2011)
High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism
Jennifer E. Griffin et al.
PLOS PATHOGENS (2011)
GLOBAL HEALTH Picking Up the Pace - Scale-Up of MDR Tuberculosis Treatment Programs
Salmaan Keshavjee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents
Bo Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease
Janine Kirstein et al.
EMBO MOLECULAR MEDICINE (2009)
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
Evan W. Orenstein et al.
LANCET INFECTIOUS DISEASES (2009)
Target identification using drug affinity responsive target stability (DARTS)
Brett Lomenick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mycobacterium tuberculosis ClpC1
Narayani P. Kar et al.
FEBS JOURNAL (2008)
ClpP: A distinctive family of cylindrical energy-dependent serine proteases
Angela Yeou Hsiung Yu et al.
FEBS LETTERS (2007)
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis
Sang Hyun Cho et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Development of an extraction method for mycobacterial metabolome analysis
BU Jaki et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2006)
Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: Insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set
I Filliol et al.
JOURNAL OF BACTERIOLOGY (2006)
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence
P Brodin et al.
INFECTION AND IMMUNITY (2006)
AAA+ proteins: Have engine, will work
PI Hanson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages
J Rengarajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis
K Falzari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
K Andries et al.
SCIENCE (2005)
A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis:: Application to Mycobacterium tuberculosis
G Lamichhane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis -: Evidence that this lipid is involved in the cell wall permeability barrier
LR Camacho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Agelasine F from a Philippine Agelas sp sponge exhibits in vitro antituberculosis activity
GC Mangalindan et al.
PLANTA MEDICA (2000)
分享论文
